Home SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
Article
Licensed
Unlicensed Requires Authentication

SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications

  • Ralf P. Friedrich , Christina Janko , Harald Unterweger , Stefan Lyer and Christoph Alexiou EMAIL logo
Published/Copyright: July 12, 2021
Become an author with De Gruyter Brill

Abstract

In the past decades, a wide variety of different superparamagnetic iron oxide nanoparticles (SPIONs) have been synthesized. Due to their unique properties, such as big surface-to-volume ratio, superparamagnetism and comparatively low toxicity, they are principally well suited for many different technical and biomedical applications. Meanwhile, there are a numerous synthesis methods for SPIONs, but high requirements for biocompatibility have so far delayed a successful translation into the clinic. Moreover, depending on the planned application, such as for imaging, magnetic drug targeting, hyperthermia or for hybrid materials intended for regenerative medicine, specific physicochemical and biological properties are inevitable. Since a summary of all existing SPION systems, their properties and application is far too extensive, this review reports on selected methods for SPION synthesis, their biocompatibility and biomedical applications.


Corresponding author: Christoph Alexiou, Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship Universitätsklinikum, Erlangen, Germany, E-mail:

Funding source: Deutsche Forschungsgemeinschaft 10.13039/501100001659

Award Identifier / Grant number: SPP1681: Grant Number: AL 552/5

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Deutsche Forschungsgemeinschaft (SPP1681: Grant Number: AL 552/5).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Ali, A, Zafar, H, Zia, M, Ul Haq, I, Phull, AR, Ali, JS, et al.. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl 2016;9:49–67. https://doi.org/10.2147/nsa.s99986.Search in Google Scholar PubMed PubMed Central

2. Gebauer, JS, Malissek, M, Simon, S, Knauer, SK, Maskos, M, Stauber, RH, et al.. Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir 2012;28:9673–9. https://doi.org/10.1021/la301104a.Search in Google Scholar PubMed

3. Faunce, TA, White, J, Matthael, KI. Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomedicine 2008;3:859–66. https://doi.org/10.2217/17435889.3.6.859.Search in Google Scholar PubMed

4. Lesniak, A, Fenaroli, F, Monopoli, MR, Aberg, C, Dawson, KA, Salvati, A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012;6:5845–57. https://doi.org/10.1021/nn300223w.Search in Google Scholar PubMed

5. Liu, TY, Hu, SH, Liu, TY, Liu, DM, Chen, SY. Magnetic-sensitive behavior of intelligent ferrogels for controlled release of drug. Langmuir 2006;22:5974–8. https://doi.org/10.1021/la060371e.Search in Google Scholar PubMed

6. Deuflhard, M, Eberbeck, D, Hietschold, P, Wilharm, N, Muhlberger, M, Friedrich, RP, et al.. Magnetically responsive composites: electron beam assisted magnetic nanoparticle arrest in gelatin hydrogels for bioactuation. Phys Chem Chem Phys 2019;21:14654–62. https://doi.org/10.1039/c9cp02910a.Search in Google Scholar PubMed

7. Laurent, S, Saei, AA, Behzadi, S, Panahifar, A, Mahmoudi, M. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expet Opin Drug Deliv 2014;11:1449–70. https://doi.org/10.1517/17425247.2014.924501.Search in Google Scholar PubMed

8. Tietze, R, Zaloga, J, Unterweger, H, Lyer, S, Friedrich, RP, Janko, C, et al.. Magnetic nanoparticle-based drug delivery for cancer therapy. Biochem Biophys Res Commun 2015;468:463–70. https://doi.org/10.1016/j.bbrc.2015.08.022.Search in Google Scholar PubMed

9. Tietze, R, Lyer, S, Durr, S, Struffert, T, Engelhorn, T, Schwarz, M, et al.. Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits. Nanomedicine 2013;9:961–71. https://doi.org/10.1016/j.nano.2013.05.001.Search in Google Scholar PubMed

10. Dürr, S, Janko, C, Lyer, S, Tripal, P, Schwarz, M, Zaloga, J, et al.. Magnetic nanoparticles for cancer therapy. Nanotechnol Rev 2013;2:395.10.1515/ntrev-2013-0011Search in Google Scholar

11. Hauser, AK, Mathias, R, Anderson, KW, Hilt, JZ. The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles. Mater Chem Phys 2015;160:177–86. https://doi.org/10.1016/j.matchemphys.2015.04.022.Search in Google Scholar PubMed PubMed Central

12. Durr, S, Lyer, S, Mann, J, Janko, C, Tietze, R, Schreiber, E, et al.. Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles. Anticancer Res 2012;32:1983–9.Search in Google Scholar

13. Lugert, S, Unterweger, H, Muhlberger, M, Janko, C, Draack, S, Ludwig, F, et al.. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2d and 3d cell culture models. Int J Nanomed 2019;14:161–80. https://doi.org/10.2147/IJN.S187886.Search in Google Scholar PubMed PubMed Central

14. Unterweger, H, Dezsi, L, Matuszak, J, Janko, C, Poettler, M, Jordan, J, et al.. Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety. Int J Nanomed 2018;13:1899–915. https://doi.org/10.2147/ijn.s156528.Search in Google Scholar PubMed PubMed Central

15. Liu, G, Gao, J, Ai, H, Chen, X. Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 2013;9:1533–45. https://doi.org/10.1002/smll.201201531.Search in Google Scholar PubMed

16. Khalafalla, S, Reimers, G. Preparation of dilution-stable aqueous magnetic fluids. IEEE Trans Magn 1980;16:178–83. https://doi.org/10.1109/tmag.1980.1060578.Search in Google Scholar

17. Zaloga, J, Pöttler, M, Leitinger, G, Friedrich, RP, Almer, G, Lyer, S, et al.. Pharmaceutical formulation of hsa hybrid coated iron oxide nanoparticles for magnetic drug targeting. Eur J Pharm Biopharm 2016;101:152–62. https://doi.org/10.1016/j.ejpb.2016.01.017.Search in Google Scholar PubMed

18. Hunt, CP, Moskowitz, BM, Banerjee, SK. Magnetic properties of rocks and minerals. Rock physics & phase relations: a handbook of physical constants. Washington DC: American Geophysical Union; 1995, vol. 3:189–204 pp.10.1029/RF003p0189Search in Google Scholar

19. Poller, JM, Zaloga, J, Schreiber, E, Unterweger, H, Janko, C, Radon, P, et al.. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Int J Nanomed 2017;12:3207–20. https://doi.org/10.2147/ijn.s132369.Search in Google Scholar PubMed PubMed Central

20. Matuszak, J, Zaloga, J, Friedrich, RP, Lyer, S, Nowak, J, Odenbach, S, et al.. Endothelial biocompatibility and accumulation of spion under flow conditions. J Magn Magn Mater 2014;380:20–6. https://doi.org/10.1016/j.jmmm.2014.09.005.Search in Google Scholar

21. Zaloga, J, Janko, C, Nowak, J, Matuszak, J, Knaup, S, Eberbeck, D, et al.. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J Nanomed 2014;9:4847–66. https://doi.org/10.2147/ijn.s68539.Search in Google Scholar PubMed PubMed Central

22. Koeller, J, Eble, M. Mitoxantrone: a novel anthracycline derivative. Clin Pharm 1988;7:574–81.Search in Google Scholar

23. LiverTox: clinical and research information on drug-induced liver injury. Mitoxantrone [Internet]. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547931/ [Updated 19 Feb 2020].Search in Google Scholar

24. Wolfram, J, Zhu, M, Yang, Y, Shen, J, Gentile, E, Paolino, D, et al.. Safety of nanoparticles in medicine. Curr Drug Targets 2015;16:1671–81. https://doi.org/10.2174/1389450115666140804124808.Search in Google Scholar PubMed PubMed Central

25. Unterweger, H, Janko, C, Schwarz, M, Dezsi, L, Urbanics, R, Matuszak, J, et al.. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Int J Nanomed 2017;12:5223–38. https://doi.org/10.2147/ijn.s138108.Search in Google Scholar PubMed PubMed Central

26. Unterweger, H, Tietze, R, Janko, C, Zaloga, J, Lyer, S, Durr, S, et al.. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery. Int J Nanomed 2014;9:3659–76. https://doi.org/10.2147/ijn.s63433.Search in Google Scholar PubMed PubMed Central

27. Mattheolabakis, G, Milane, L, Singh, A, Amiji, MM. Hyaluronic acid targeting of cd44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target 2015;23:605–18. https://doi.org/10.3109/1061186x.2015.1052072.Search in Google Scholar PubMed

28. Dasari, S, Tchounwou, PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 2014;740:364–78. https://doi.org/10.1016/j.ejphar.2014.07.025.Search in Google Scholar PubMed PubMed Central

29. Zhang, W, Tung, CH. Cisplatin cross-linked multifunctional nanodrugplexes for combination therapy. ACS Appl Mater Interfaces 2017;9:8547–55. https://doi.org/10.1021/acsami.6b16500.Search in Google Scholar PubMed

30. Foroozandeh, P, Aziz, AA. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett 2018;13:339. https://doi.org/10.1186/s11671-018-2728-6.Search in Google Scholar PubMed PubMed Central

31. Zupke, O, Distler, E, Jurchott, A, Paiphansiri, U, Dass, M, Thomas, S, et al.. Nanoparticles and antigen-specific t-cell therapeutics: a comprehensive study on uptake and release. Nanomedicine 2015;10:1063–76. https://doi.org/10.2217/nnm.14.160.Search in Google Scholar PubMed

32. Mühlberger, M, Janko, C, Unterweger, H, Schreiber, E, Band, J, Lehmann, C, et al.. Functionalization of t lymphocytes for magnetically controlled immune therapy: selection of suitable superparamagnetic iron oxide nanoparticles. J Magn Magn Mater 2019;473:61–7. https://doi.org/10.1016/j.jmmm.2018.10.022.Search in Google Scholar

33. Muhlberger, M, Janko, C, Unterweger, H, Band, J, Schreiber, E, Lehmann, C, et al.. Non-magnetic chromatographic separation of colloidally metastable superparamagnetic iron oxide nanoparticles and suspension cells. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1122–1123:83–9. https://doi.org/10.1016/j.jchromb.2019.05.033.Search in Google Scholar PubMed

34. Mühlberger, M, Janko, C, Unterweger, H, Friedrich, R, Friedrich, B, Band, J, et al.. Functionalization of t lymphocytes with citrate-coated superparamagnetic iron oxide nanoparticles for magnetically controlled immune therapy. Int J Nanomed 2019;14:8421–32. https://doi.org/10.2147/ijn.s218488.Search in Google Scholar PubMed PubMed Central

35. Hunt, CP, Singer, MJ, Kletetschka, G, TenPas, J, Verosub, KL. Effect of citrate-bicarbonate-dithionite treatment on fine-grained magnetite and maghemite. Earth Planet Sci Lett 1995;130:87–94. https://doi.org/10.1016/0012-821x(94)00256-x.Search in Google Scholar

36. Friedrich, RP, Zaloga, J, Schreiber, E, Toth, IY, Tombacz, E, Lyer, S, et al.. Tissue plasminogen activator binding to superparamagnetic iron oxide nanoparticle-covalent versus adsorptive approach. Nanoscale Res Lett 2016;11:297. https://doi.org/10.1186/s11671-016-1521-7.Search in Google Scholar PubMed PubMed Central

37. Toth, IY, Illes, E, Bauer, RA, Nesztor, D, Szekeres, M, Zupko, I, et al.. Designed polyelectrolyte shell on magnetite nanocore for dilution-resistant biocompatible magnetic fluids. Langmuir 2012;28:16638–46. https://doi.org/10.1021/la302660p.Search in Google Scholar PubMed

38. Dalwadi, G, Benson, HA, Chen, Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm Res (N Y) 2005;22:2152–62. https://doi.org/10.1007/s11095-005-7781-z.Search in Google Scholar PubMed

39. Zaloga, J, Stapf, M, Nowak, J, Pottler, M, Friedrich, RP, Tietze, R, et al.. Tangential flow ultrafiltration allows purification and concentration of lauric acid-/albumin-coated particles for improved magnetic treatment. Int J Mol Sci 2015;16:19291–307. https://doi.org/10.3390/ijms160819291.Search in Google Scholar PubMed PubMed Central

40. Oberle, A, Ludtke-Buzug, K. Stability analysis of superparamagnetic iron oxide nanoparticles (spions) at 37 degrees c. Biomed Tech 2013;58(1 Suppl). https://doi.org/10.1515/bmt-2013-4099.Search in Google Scholar PubMed

41. Zaloga, J, Janko, C, Agarwal, R, Nowak, J, Muller, R, Boccaccini, AR, et al.. Different storage conditions influence biocompatibility and physicochemical properties of iron oxide nanoparticles. Int J Mol Sci 2015;16:9368–84. https://doi.org/10.3390/ijms16059368.Search in Google Scholar PubMed PubMed Central

42. Friedrich, RP, Janko, C, Poettler, M, Tripal, P, Zaloga, J, Cicha, I, et al.. Flow cytometry for intracellular spion quantification: specificity and sensitivity in comparison with spectroscopic methods. Int J Nanomed 2015;10:4185–201. https://doi.org/10.2147/ijn.s82714.Search in Google Scholar

43. Turcu, R, Craciunescu, I, Garamus, VM, Janko, C, Lyer, S, Tietze, R, et al.. Magnetic microgels for drug targeting applications: physical–chemical properties and cytotoxicity evaluation. J Magn Magn Mater 2015;380:307–14. https://doi.org/10.1016/j.jmmm.2014.08.041.Search in Google Scholar

44. Li, W, Jan, Z, Ding, Y, Liu, Y, Janko, C, Pischetsrieder, M, et al.. Facile preparation of multifunctional superparamagnetic phbv microspheres containing spions for biomedical applications. Sci Rep 2016;6:23140. https://doi.org/10.1038/srep23140.Search in Google Scholar PubMed PubMed Central

45. Lucht, N, Friedrich, PR, Draack, S, Alexiou, C, Viereck, T, Ludwig, F, et al.. Biophysical characterization of (silica-coated) cobalt ferrite nanoparticles for hyperthermia treatment. Nanomaterials 2019;9. https://doi.org/10.3390/nano9121713.Search in Google Scholar PubMed PubMed Central

46. Matuszak, J, Baumgartner, J, Zaloga, J, Juenet, M, da Silva, AE, Franke, D, et al.. Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing. Nanomedicine 2016;11:597–616. https://doi.org/10.2217/nnm.15.216.Search in Google Scholar PubMed

47. Tietze, R, Rahn, H, Lyer, S, Schreiber, E, Mann, J, Odenbach, S, et al.. Visualization of superparamagnetic nanoparticles in vascular tissue using xmuct and histology. Histochem Cell Biol 2011;135:153–8. https://doi.org/10.1007/s00418-011-0780-8.Search in Google Scholar PubMed

48. Hornung, A, Poettler, M, Friedrich, RP, Zaloga, J, Unterweger, H, Lyer, S, et al.. Treatment efficiency of free and nanoparticle-loaded mitoxantrone for magnetic drug targeting in multicellular tumor spheroids. Molecules 2015;20:18016–30. https://doi.org/10.3390/molecules201018016.Search in Google Scholar PubMed PubMed Central

49. Thoma, CR, Zimmermann, M, Agarkova, I, Kelm, JM, Krek, W. 3d cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 2014;69-70:29–41. https://doi.org/10.1016/j.addr.2014.03.001.Search in Google Scholar PubMed

50. Hornung, A, Poettler, M, Friedrich, RP, Weigel, B, Duerr, S, Zaloga, J, et al.. Toxicity of mitoxantrone-loaded superparamagnetic iron oxide nanoparticles in a ht-29 tumour spheroid model. Anticancer Res 2016;36:3093–101.Search in Google Scholar

51. Zaloga, J, Feoktystov, A, Garamus, VM, Karawacka, W, Ioffe, A, Bruckel, T, et al.. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles. Colloids Surf B Biointerfaces 2018;161:18–26. https://doi.org/10.1016/j.colsurfb.2017.09.057.Search in Google Scholar PubMed

52. Stage, TB, Bergmann, TK, Kroetz, DL. Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review. Clin Pharmacokinet 2018;57:7–19. https://doi.org/10.1007/s40262-017-0563-z.Search in Google Scholar PubMed PubMed Central

53. Kundranda, MN, Niu, J. Albumin-bound paclitaxel in solid tumors: clinical development and future directions. Drug Des Dev Ther 2015;9:3767–77. https://doi.org/10.2147/dddt.s88023.Search in Google Scholar PubMed PubMed Central

54. Jiang, G, Zhang, S, Yazdanparast, A, Li, M, Pawar, AV, Liu, Y, et al.. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genom 2016;17(7 Suppl):525. https://doi.org/10.1186/s12864-016-2911-z.Search in Google Scholar PubMed PubMed Central

55. Chekhun, S, Bezdenezhnykh, N, Shvets, J, Lukianova, N. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Exp Oncol 2013;35:174–9.Search in Google Scholar

56. Brabers, VAM. Progress in spinel ferrite research. Handbook of magnetic materials 8. Amsterdam – Lausanne – New York – Oxford – Tokyo: Elsevier; 1995, vol 8:199–344 pp.Search in Google Scholar

57. Lyer, S, Tietze, R, Unterweger, H, Zaloga, J, Singh, R, Matuszak, J, et al.. Nanomedical innovation: the seon-concept for an improved cancer therapy with magnetic nanoparticles. Nanomedicine 2015;10:3287–304. https://doi.org/10.2217/nnm.15.159.Search in Google Scholar PubMed

58. Janko, C, Zaloga, J, Pöttler, M, Dürr, S, Eberbeck, D, Tietze, R, et al.. Strategies to optimize the biocompatibility of iron oxide nanoparticles – “spions safe by design”. J Magn Magn Mater 2017;431:281–4. https://doi.org/10.1016/j.jmmm.2016.09.034.Search in Google Scholar

59. Fuchs, TA, Abed, U, Goosmann, C, Hurwitz, R, Schulze, I, Wahn, V, et al.. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007;176:231–41. https://doi.org/10.1083/jcb.200606027.Search in Google Scholar PubMed PubMed Central

60. Manfredi, AA, Covino, C, Rovere-Querini, P, Maugeri, N. Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin Exp Immunol 2015;179:24–9. https://doi.org/10.1111/cei.12320.Search in Google Scholar PubMed PubMed Central

61. Chen, K, Nishi, H, Travers, R, Tsuboi, N, Martinod, K, Wagner, DD, et al.. Endocytosis of soluble immune complexes leads to their clearance by fcgammariiib but induces neutrophil extracellular traps via fcgammariia in vivo. Blood 2012;120:4421–31. https://doi.org/10.1182/blood-2011-12-401133.Search in Google Scholar PubMed PubMed Central

62. Maueroder, C, Mahajan, A, Paulus, S, Gosswein, S, Hahn, J, Kienhofer, D, et al.. Menage-a-trois: the ratio of bicarbonate to co2 and the ph regulate the capacity of neutrophils to form nets. Front Immunol 2016;7:583. https://doi.org/10.3389/fimmu.2016.00583.Search in Google Scholar PubMed PubMed Central

63. Munoz, LE, Bilyy, R, Biermann, MH, Kienhofer, D, Maueroder, C, Hahn, J, et al.. Nanoparticles size-dependently initiate self-limiting netosis-driven inflammation. Proc Natl Acad Sci U S A 2016;113:E5856–65. https://doi.org/10.1073/pnas.1602230113.Search in Google Scholar PubMed PubMed Central

64. Bilyy, R, Unterweger, H, Weigel, B, Dumych, T, Paryzhak, S, Vovk, V, et al.. Inert coats of magnetic nanoparticles prevent formation of occlusive intravascular co-aggregates with neutrophil extracellular traps. Front Immunol 2018;9:2266. https://doi.org/10.3389/fimmu.2018.02266.Search in Google Scholar PubMed PubMed Central

65. Lee, EA, Yim, H, Heo, J, Kim, H, Jung, G, Hwang, NS. Application of magnetic nanoparticle for controlled tissue assembly and tissue engineering. Arch Pharm Res 2014;37:120–8. https://doi.org/10.1007/s12272-013-0303-3.Search in Google Scholar PubMed

66. Connell, JJ, Patrick, PS, Yu, Y, Lythgoe, MF, Kalber, TL. Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles. Regen Med 2015;10:757–72. https://doi.org/10.2217/rme.15.36.Search in Google Scholar PubMed

67. Lanitis, E, Dangaj, D, Irving, M, Coukos, G. Mechanisms regulating t-cell infiltration and activity in solid tumors. Ann Oncol 2017;28:xii18–32. https://doi.org/10.1093/annonc/mdx238.Search in Google Scholar PubMed

68. Sanz-Ortega, L, Rojas, JM, Marcos, A, Portilla, Y, Stein, JV, Barber, DF. T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field. J Nanobiotechnol 2019;17. https://doi.org/10.1186/s12951-019-0440-z.Search in Google Scholar PubMed PubMed Central

69. Newick, K, O’Brien, S, Moon, E, Albelda, SM. Car t cell therapy for solid tumors. Annu Rev Med 2017;68:139–52. https://doi.org/10.1146/annurev-med-062315-120245.Search in Google Scholar PubMed

70. Klinkert, P, Post, PN, Breslau, PJ, van Bocke, JH. Saphenous vein versus ptfe for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357–62. https://doi.org/10.1016/j.ejvs.2003.12.027.Search in Google Scholar PubMed

71. Hamon, M, Lecluse, E, Monassier, JP, Grollier, G, Potier, JC. Pharmacological approaches to the prevention of restenosis after coronary angioplasty. Drugs Aging 1998;13:291–301. https://doi.org/10.2165/00002512-199813040-00005.Search in Google Scholar PubMed

72. Piterina, AV, Cloonan, AJ, Meaney, CL, Davis, LM, Callanan, A, Walsh, MT, et al.. Ecm-based materials in cardiovascular applications: inherent healing potential and augmentation of native regenerative processes. Int J Mol Sci 2009;10:4375–417. https://doi.org/10.3390/ijms10104375.Search in Google Scholar PubMed PubMed Central

73. Khan, OF, Sefton, MV. Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol 2011;29:379–87. https://doi.org/10.1016/j.tibtech.2011.03.004.Search in Google Scholar PubMed PubMed Central

74. Hsu, SH, Tsai, I, Lin, DJ, Chen, DC. The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys 2005;27:267–72. https://doi.org/10.1016/j.medengphy.2004.10.008.Search in Google Scholar PubMed

75. Melchiorri, AJ, Bracaglia, LG, Kimerer, LK, Hibino, N, Fisher, JP. In vitro endothelialization of biodegradable vascular grafts via endothelial progenitor cell seeding and maturation in a tubular perfusion system bioreactor. Tissue Eng C Methods 2016;22:663–70. https://doi.org/10.1089/ten.tec.2015.0562.Search in Google Scholar

76. Perea, H, Aigner, J, Hopfner, U, Wintermantel, E. Magnetically induced cell seeding of tubular scaffolds for vascular tissue engineering. Tissue Eng 2006;12:1085–6.Search in Google Scholar

77. Wisotzki, EI, Friedrich, RP, Weidt, A, Alexiou, C, Mayr, SG, Zink, M. Cellular response to reagent-free electron-irradiated gelatin hydrogels. Macromol Biosci 2016;16:914–24. https://doi.org/10.1002/mabi.201500408.Search in Google Scholar PubMed

78. Tadsen, M, Friedrich, RP, Riedel, S, Alexiou, C, Mayr, SG. Contact guidance by microstructured gelatin hydrogels for prospective tissue engineering applications. ACS Appl Mater Interfaces 2019;11:7450–8. https://doi.org/10.1021/acsami.8b21638.Search in Google Scholar PubMed

79. Jackson, SP. Arterial thrombosis--insidious, unpredictable and deadly. Nat Med 2011;17:1423–36. https://doi.org/10.1038/nm.2515.Search in Google Scholar PubMed

80. Dimarsico, L, Cymet, T. Pulmonary embolism--a state of the clot review. Compr Ther 2007;33:184–91. https://doi.org/10.1007/s12019-007-8015-6.Search in Google Scholar PubMed

81. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engl J Med 1995;333:1581–7. https://doi.org/10.1056/NEJM199512143332401.Search in Google Scholar PubMed

82. Zhang, J, Yang, Y, Sun, H, Xing, Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med 2014;2:81. https://doi.org/10.3978/j.issn.2305-5839.2014.08.08.Search in Google Scholar PubMed PubMed Central

83. Depta, JP, Bhatt, DL. New approaches to inhibiting platelets and coagulation. Annu Rev Pharmacol Toxicol 2015;55:373–97. https://doi.org/10.1146/annurev-pharmtox-010814-124438.Search in Google Scholar PubMed

84. Ageno, W, Spyropoulos, AC, Turpie, AG. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients. Thromb Haemostasis 2012;107:1027–34. https://doi.org/10.1160/th11-11-0787.Search in Google Scholar

85. Chapman, SN, Mehndiratta, P, Johansen, MC, McMurry, TL, Johnston, KC, Southerland, AM. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tpa) for treatment of acute ischemic stroke. Vasc Health Risk Manag 2014;10:75–87. https://doi.org/10.2147/VHRM.S39213.Search in Google Scholar PubMed PubMed Central

86. Chen, Y, Cui, G, Zhao, M, Wang, C, Qian, K, Morris-Natschke, S, et al.. Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing l-arg and l-asp or l-glu. Bioorg Med Chem 2008;16:5914–25. https://doi.org/10.1016/j.bmc.2008.04.064.Search in Google Scholar PubMed

87. Jin, S, Wang, Y, Zhu, H, Wang, Y, Zhao, S, Zhao, M, et al.. Nanosized aspirin-arg-gly-asp-val: delivery of aspirin to thrombus by the target carrier arg-gly-asp-val tetrapeptide. ACS Nano 2013;7:7664–73. https://doi.org/10.1021/nn402171v.Search in Google Scholar PubMed

88. Tang, AC, Chang, MY, Tang, ZC, Li, HJ, Hwang, GL, Hsieh, PC. Treatment of acute thromboembolism in mice using heparin-conjugated carbon nanocapsules. ACS Nano 2012;6:6099–107. https://doi.org/10.1021/nn301198r.Search in Google Scholar PubMed

89. Ji, J, Ji, SY, Yang, JA, He, X, Yang, XH, Ling, WP, et al.. Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement. Int J Nanomed 2012;7:2911–9. https://doi.org/10.2147/ijn.s32363.Search in Google Scholar PubMed PubMed Central

90. Tadayon, A, Jamshidi, R, Esmaeili, A. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases. Int J Pharm 2015;495:428–38. https://doi.org/10.1016/j.ijpharm.2015.09.008.Search in Google Scholar PubMed

91. Peters, D, Kastantin, M, Kotamraju, VR, Karmali, PP, Gujraty, K, Tirrell, M, et al.. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A 2009;106:9815–9. https://doi.org/10.1073/pnas.0903369106.Search in Google Scholar PubMed PubMed Central

92. Ma, YH, Wu, SY, Wu, T, Chang, YJ, Hua, MY, Chen, JP. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials 2009;30:3343–51. https://doi.org/10.1016/j.biomaterials.2009.02.034.Search in Google Scholar PubMed

93. Bi, F, Zhang, J, Su, Y, Tang, YC, Liu, JN. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials 2009;30:5125–30. https://doi.org/10.1016/j.biomaterials.2009.06.006.Search in Google Scholar PubMed

94. Zhou, J, Guo, D, Zhang, Y, Wu, W, Ran, H, Wang, Z. Construction and evaluation of fe(3)o(4)-based plga nanoparticles carrying rtpa used in the detection of thrombosis and in targeted thrombolysis. ACS Appl Mater Interfaces 2014;6:5566–76. https://doi.org/10.1021/am406008k.Search in Google Scholar PubMed

95. Kawata, H, Uesugi, Y, Soeda, T, Takemoto, Y, Sung, JH, Umaki, K, et al.. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J Am Coll Cardiol 2012;60:2550–7. https://doi.org/10.1016/j.jacc.2012.08.1008.Search in Google Scholar PubMed

96. McCarthy, JR, Sazonova, IY, Erdem, SS, Hara, T, Thompson, BD, Patel, P, et al.. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy. Nanomedicine 2012;7:1017–28. https://doi.org/10.2217/nnm.11.179.Search in Google Scholar PubMed PubMed Central

97. Heid, S, Unterweger, H, Tietze, R, Friedrich, RP, Weigel, B, Cicha, I, et al.. Synthesis and characterization of tissue plasminogen activator-functionalized superparamagnetic iron oxide nanoparticles for targeted fibrin clot dissolution. Int J Mol Sci 2017;18. https://doi.org/10.3390/ijms18091837.Search in Google Scholar PubMed PubMed Central

98. Veiseh, O, Gunn, JW, Zhang, M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010;62:284–304. https://doi.org/10.1016/j.addr.2009.11.002.Search in Google Scholar PubMed PubMed Central

Received: 2020-01-16
Accepted: 2021-06-08
Published Online: 2021-07-12

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Influence of lime (CaO) on low temperature leaching of some types of bauxite from Guinea
  4. Ethnobotanical survey, phytoconstituents and antibacterial investigation of Rapanea melanophloeos (L.) Mez. bark, fruit and leaf extracts
  5. Catalytic properties of supramolecular polymetallated porphyrins
  6. Lignin-based polymers
  7. Bio-based polyhydroxyalkanoates blends and composites
  8. Biodegradable poly(butylene adipate-co-terephthalate) (PBAT)
  9. Repurposing tires – alternate energy source?
  10. Theoretical investigation of the stability, reactivity, and the interaction of methyl-substituted peridinium-based ionic liquids
  11. Polymeric membranes for biomedical applications
  12. Design of locally sourced activated charcoal filter from maize cob for wastewater decontamination: an approach to fight waste with waste
  13. Synthesis of biologically active heterocyclic compounds from allenic and acetylenic nitriles and related compounds
  14. Magnetic measurement methods to probe nanoparticle–matrix interactions
  15. Health and exposure risk assessment of heavy metals in rainwater samples from selected locations in Rivers State, Nigeria
  16. Evaluation of raw, treated and effluent water quality from selected water treatment plants: a case study of Lagos Water Corporation
  17. A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products
  18. Hemicyanine dyes
  19. Thermodynamics of the micellization of quaternary based cationic surfactants in triethanolamine-water media: a conductometry study
  20. Compounds isolated from hexane fraction of Alternanthera brasiliensis show synergistic activity against methicillin resistant Staphylococcus aureus
  21. Internal structures and mechanical properties of magnetic gels and suspensions
  22. SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
  23. Magnetic field controlled behavior of magnetic gels studied using particle-based simulations
  24. The microstructure of magnetorheological materials characterized by means of computed X-ray microtomography
  25. Core-modified porphyrins: novel building blocks in chemistry
  26. Anticancer potential of indole derivatives: an update
  27. Novel drug design and bioinformatics: an introduction
  28. Multi-objective optimization of CCUS supply chains for European countries with higher carbon dioxide emissions
  29. Exergy analysis of an atmospheric residue desulphurization hydrotreating process for a crude oil refinery
  30. Development in nanomembrane-based filtration of emerging contaminants
  31. Supply chain optimization framework for CO2 capture, utilization, and storage in Germany
  32. Naturally occurring heterocyclic anticancer compounds
  33. Part-II- in silico drug design: application and success
  34. Advances in biopolymer composites and biomaterials for the removal of emerging contaminants
  35. Nanobiocatalysts and photocatalyst in dye degradation
  36. 3D tumor model – a platform for anticancer drug development
  37. Hydrogen production via water splitting over graphitic carbon nitride (g-C3N4 )-based photocatalysis
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/psr-2019-0093/html
Scroll to top button